Teva Pharmaceuticals USA recalls Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0
Recalled July 23, 2014 · FDA recall D-1439-2014 · Teva Pharmaceuticals USA
Hazard
Failed Impurities/Degradation Specifications: out of specification impurity test results. · FDA Class III
Units
5265 blister packs
Sold at
Nationwide
Description
Failed Impurities/Degradation Specifications: out of specification impurity test results.
Product
Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY NDC 0555-9051-67
Manufacturer(s)
Teva Pharmaceuticals USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →